322 related articles for article (PubMed ID: 16641879)
21. Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease.
Urashima S; Tsutsumi M; Ozaki K; Tsuchishima M; Shimanaka K; Ueshima Y; Takase S
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):34S-38S. PubMed ID: 10803777
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
23. Pro-inflammatory cytokines in stable chronic alcoholics: relationship with fat and lean mass.
González-Reimers E; García-Valdecasas-Campelo E; Santolaria-Fernández F; de la Vega-Prieto MJ; Ros-Vilamajó R; Martínez-Riera A; Castellano-Higuera A; Rodríguez-Gaspar M
Food Chem Toxicol; 2007 Jun; 45(6):904-9. PubMed ID: 17210215
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease.
Tsutsumi M; Urashima S; Takase S; Ueshima Y; Tsuchishima M; Shimanaka K; Kawahara H
Alcohol Clin Exp Res; 1997 Dec; 21(9):1716-21. PubMed ID: 9438536
[TBL] [Abstract][Full Text] [Related]
25. Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.
Liu YS; Xu GY; Cheng DQ; Li YM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):265-8. PubMed ID: 15908327
[TBL] [Abstract][Full Text] [Related]
26. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration.
Sheron N; Bird G; Koskinas J; Portmann B; Ceska M; Lindley I; Williams R
Hepatology; 1993 Jul; 18(1):41-6. PubMed ID: 8325620
[TBL] [Abstract][Full Text] [Related]
27. Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease.
Nishimura M; Hasumura Y; Takeuchi J
Gastroenterology; 1980 Apr; 78(4):691-5. PubMed ID: 7353755
[TBL] [Abstract][Full Text] [Related]
28. IgA deposition in liver in alcoholic liver disease. An index of progressive injury.
Swerdlow MA; Chowdhury LN
Arch Pathol Lab Med; 1984 May; 108(5):416-9. PubMed ID: 6370194
[TBL] [Abstract][Full Text] [Related]
29. [National survey of alcoholic liver disease in Japan].
Horie Y; Ishii H; Hibi T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec; 39(6):505-10. PubMed ID: 15675363
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease.
Stewart SF; Vidali M; Day CP; Albano E; Jones DE
Hepatology; 2004 Jan; 39(1):197-203. PubMed ID: 14752838
[TBL] [Abstract][Full Text] [Related]
31. Role of serum interleukin-8 and intercellular adhesion molecule-1 in the severity of alcoholic hepatitis.
Ishii K; Furudera S; Kumashiro R; Seo J; Koga Y; Sata M; Tanikawa K
Alcohol Alcohol Suppl; 1994; 29(1):81-5. PubMed ID: 9063824
[TBL] [Abstract][Full Text] [Related]
32. Immunologic aspects of alcoholic liver disease.
Zetterman RK; Sorrell MF
Gastroenterology; 1981 Sep; 81(3):616-24. PubMed ID: 6166511
[TBL] [Abstract][Full Text] [Related]
33. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
Dominguez M; Miquel R; Colmenero J; Moreno M; García-Pagán JC; Bosch J; Arroyo V; Ginès P; Caballería J; Bataller R
Gastroenterology; 2009 May; 136(5):1639-50. PubMed ID: 19208360
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating immune complexes in alcoholic liver disease.
Penner E; Albini B; Milgrom F
Clin Exp Immunol; 1978 Oct; 34(1):28-31. PubMed ID: 373931
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characteristics and prognostic criteria in alcoholic hepatitis and alcoholic hepatitis with cirrhosis].
García Rodríguez JF; Tomé Martínez de Rituerto S; Martínez Vázquez F; Gude Sanpedro F; Rodríguez López I; Barrio Gómez E
Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):210-4. PubMed ID: 2813910
[TBL] [Abstract][Full Text] [Related]
36. Utility of gamma-glutamyl transpeptidase and mean corpuscular volume in alcoholic liver disease.
Baral N; Pokhrel S; Lamsal M; Yadav BN; Sah SP
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):1007-10. PubMed ID: 16295559
[TBL] [Abstract][Full Text] [Related]
37. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease.
Naveau S; Cassard-Doulcier AM; Njiké-Nakseu M; Bouchet-Delbos L; Barri-Ova N; Boujedidi H; Dauvois B; Balian A; Maitre S; Prévot S; Dagher I; Agostini H; Grangeot-Keros L; Emilie D; Perlemuter G
J Hepatol; 2010 Jun; 52(6):895-902. PubMed ID: 20399524
[TBL] [Abstract][Full Text] [Related]
38. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic significance of determining the blood content of lactic and uric acids in chronic liver lesions of alcoholic and viral etiologies].
Loginov AS; Dzhalalov KD; Blok IuE
Ter Arkh; 1985; 57(9):87-91. PubMed ID: 4082057
[TBL] [Abstract][Full Text] [Related]
40. [Alcohol and liver diseases].
Weigand K; Kühn HA
Med Klin; 1980 Jul; 75(14):506-10. PubMed ID: 7402166
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
